SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-003004
Filing Date
2024-05-06
Accepted
2024-05-06 12:14:14
Documents
17
Period of Report
2024-05-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sunshine_8k.htm   iXBRL 8-K 30156
2 LETTER FROM BORGERS sunshine_ex1601.htm EX-16.1 2173
3 GRAPHIC image_004.jpg GRAPHIC 3471
4 GRAPHIC image_006.jpg GRAPHIC 13769
  Complete submission text file 0001683168-24-003004.txt   274724

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sbfm-20240503.xsd EX-101.SCH 3553
6 XBRL DEFINITION FILE sbfm-20240503_def.xml EX-101.DEF 26585
7 XBRL LABEL FILE sbfm-20240503_lab.xml EX-101.LAB 36550
8 XBRL PRESENTATION FILE sbfm-20240503_pre.xml EX-101.PRE 25209
20 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5523
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 24916526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)